100
in infants and preschoolers with
recurrent wheezing and asthma: a
systematic review with meta-analy-
sis. Pediatrics 2009; 123:e519.
31.
Ducharme FM, Lemire C, Noya FJ,
Davis GM, Alos N, Leblond H, Sa-
vdie C, Collet JP, Khomenko L, Ri-
vard G, Platt RW. Preemptive use of
high-dose fluticasone for virus-in-
duced wheezing in young children.
N Engl J Med. 2009;360(4):339.
32.
Bacharier LB, Phillips BR, Zeiger
RS, Szefler SJ, Martinez FD, Leman-
ske RF Jr, Sorkness CA, Bloomberg
GR, Morgan WJ, Paul IM, Guilbert
T, Krawiec M, Covar R, Larsen G,
Mellon M, Moss MH, Chinchilli VM,
Taussig LM, Strunk RC, CARE Net-
work. Episodic use of an inhaled
corticosteroid or leukotriene recep-
tor antagonist in preschool children
with moderate-to-severe intermit-
tent wheezing. J Allergy Clin Immu-
nol. 2008;122(6):1127
33.
Zeiger RS, Mauger D, Bacharier
LB, Guilbert TW, Martinez FD, Le-
manske RF Jr, Strunk RC, Covar R,
Szefler SJ, Boehmer S, Jackson DJ,
Sorkness CA, Gern JE, Kelly HW,
Friedman NJ, Mellon MH, Schatz M,
Morgan WJ, Chinchilli VM, Raissy
HH, Bade E, Malka-Rais J, Beigel-
man A, Taussig LM, CARE Network
of the National Heart, Lung, and
Blood Institute. Daily or intermittent
budesonide in preschool children
with recurrent wheezing. N Engl J
Med. 2011 Nov;365(21):1990-2001.
34.
Papi A, Nicolini G, Baraldi E, Bon-
er AL, Cutrera R, Rossi GA, Fabbri
LM, BEclomethasone and Salbu-
tamolTreatment (BEST) for Children
Study GroupRegular vs prn nebu-
lized treatment in wheeze preschool
children.Allergy. 2009;64(10):1463.
35.
GuilbertTW, MorganWJ, Zeiger RS,
Mauger DT, Boehmer SJ, Szefler SJ
et al. Long-term inhaled corticoste-
22.
Noble V, Ruggins NR, Everard ML,
Milner AD. Inhaled budesonide for
chronic wheezing under 18 months
of age. Arch Dis Child 1992; 67: 285-
288.
23.
De Blic J, Delacourt C, Le Bourgeois
M, Mahut B, Ostinelli J, Caswell C.
Eficacy of nebulized budesonide in
treatment of severe infantile asth-
ma: A double – blind study. J Aller-
gy Clin Immunol 1996; 67: 285 -8
24.
McKean M, Ducharme F. Inhaled
steroids for episodic viral wheeze of
childhood. Cochrane Database Syst
Rev 2000; CD001107-
25.
Roorda RJ, Mezei G, Bisgaard H,
Maden C. Response of preschool
children with asthma sympstoms
to fluticasone propionate J Allergy
Clin Immunol 2001; 108: 540-46
26.
Chavasse RJ, Bastian – Lee Y, Rich-
ter H, HilliardT, Seddon P. Persistent
wheezing in infants with an atopic
tendency responds to inhaled fluti-
casone. Arch Dis Child 2001; 85:143-
147
27.
Teper AM, Colom AJ, Kofman CD,
Maffey AF, Vidaurreta SM, Bergada
I. Effects of inhaled fluticasone pro-
pionate in children less than 2 years
old with recurrent wheezing. Pedia-
tr Pulmonol 2004; 37: 111-115.
28.
Teper AM, Kofman CD, Szulman GA,
Vidaurreta SM, Maffey AF. Fluticaso-
ne improves pulmonary function in
children under 2 years old with risk
factors for asthma. Am J Respir Crit
Care Med 2005; 171: 587-590.
29.
Hofhuis W, van der Wiel EC,
Nieuwhof EM, Hop WC, Affourtit
MJ, Smit FJ et al. Efficacy of flutica-
sone propionate on lung function
and symptoms in wheezy infants.
Am J Respir Crit Care Med 2005;
171: 328-333.
30.
Castro-Rodriguez JA, Rodrigo GJ.
Efficacy of inhaled corticosteroids
Niño con sibilancias recurrentes por debajo de los 3 años. Estrategias terapeúticas…
